Zuo, Z.; Wen, R.; Jing, S.; Chen, X.; Liu, R.; Xue, J.; Zhang, L.; Li, Q.
Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes. Pharmaceuticals 2024, 17, 1695.
https://doi.org/10.3390/ph17121695
AMA Style
Zuo Z, Wen R, Jing S, Chen X, Liu R, Xue J, Zhang L, Li Q.
Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes. Pharmaceuticals. 2024; 17(12):1695.
https://doi.org/10.3390/ph17121695
Chicago/Turabian Style
Zuo, Zanwen, Ruihua Wen, Shuang Jing, Xianghui Chen, Ruisang Liu, Jianping Xue, Lei Zhang, and Qizhang Li.
2024. "Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes" Pharmaceuticals 17, no. 12: 1695.
https://doi.org/10.3390/ph17121695
APA Style
Zuo, Z., Wen, R., Jing, S., Chen, X., Liu, R., Xue, J., Zhang, L., & Li, Q.
(2024). Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes. Pharmaceuticals, 17(12), 1695.
https://doi.org/10.3390/ph17121695
